EURORDIS statement on the proposal for a regulation on HTA cooperation in Europe

Transparency and Health Technology Assessment cooperation as proposed by the Regulation are the only real antidote to secrecy and political games. 

Why EURORDIS supports the proposal for a regulation on health technology assessment (HTA) Cooperation in Europe.

After more than 30 years of voluntary cooperation on HTA funded by the European Commission, the European Commission is now proposing a permanent and sustainable scientific secretariat for high-quality and transparent HTA cooperation in the European Union.

EURORDIS has published a statement of support for the European Commission's proposal for a regulation on health technology assessment (HTA) cooperation in Europe.

>>> Read the full statement.

>>> Read the annex that explains the HTA legislative proposal.

The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseases, Rare Diseases International is a EURORDIS initiativeRare Disease International Bringing together patients, families and experts to share experiences in a moderated multilanguage forum, RareConnect is a EURORDIS initiative RareConnect The Rare Barometer Programme is a EURORDIS initiative that carries out surveys to transform rare disease patients' experiences into figures and facts that can be shared with decision-makers.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases